1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Dysthymia Global Clinical Trials Review, H1, 2014

Dysthymia Global Clinical Trials Review, H1, 2014

  • June 2014
  • -
  • Global Data
  • -
  • 66 pages

Dysthymia Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Dysthymia Global Clinical Trials Review, H1, 2014" provides data on the Dysthymia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dysthymia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dysthymia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Dysthymia Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Dysthymia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Dysthymia to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Dysthymia to Central Nervous System Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Dysthymia Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Sanofi 27
Clinical Trial Overview of Sanofi 27
COLUMBIA NORTHWEST PHARMACEUTICALS 28
Clinical Trial Overview of COLUMBIA NORTHWEST PHARMACEUTICALS 28
Auckland UniServices Limited 29
Clinical Trial Overview of Auckland UniServices Limited 29
AB Science 30
Clinical Trial Overview of AB Science 30
Clinical Trial Overview of Top Institutes / Government 31
New York State Psychiatric Institute 31
Clinical Trial Overview of New York State Psychiatric Institute 31
Centre for Addiction and Mental Health 32
Clinical Trial Overview of Centre for Addiction and Mental Health 32
University of Washington 33
Clinical Trial Overview of University of Washington 33
University Hospital Freiburg 34
Clinical Trial Overview of University Hospital Freiburg 34
St. Luke's-Roosevelt Hospital Center 35
Clinical Trial Overview of St. Luke's-Roosevelt Hospital Center 35
University of Barcelona 36
Clinical Trial Overview of University of Barcelona 36
University of California, Los Angeles 37
Clinical Trial Overview of University of California, Los Angeles 37
The Sheba Medical Center 38
Clinical Trial Overview of The Sheba Medical Center 38
Sunnybrook Health Sciences Centre 39
Clinical Trial Overview of Sunnybrook Health Sciences Centre 39
Oregon Health and Science University 40
Clinical Trial Overview of Oregon Health and Science University 40
Five Key Clinical Profiles 41
Appendix 64
Abbreviations 64
Definitions 64
Research Methodology 65
Secondary Research 65
About GlobalData 66
Contact Us 66
Disclaimer 66
Source 66

List of Tables
Dysthymia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Dysthymia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Dysthymia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Dysthymia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Dysthymia Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Dysthymia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Dysthymia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Dysthymia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Dysthymia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Dysthymia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Dysthymia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Dysthymia Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Dysthymia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Dysthymia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Dysthymia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Dysthymia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Dysthymia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Dysthymia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Dysthymia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Dysthymia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 27
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by COLUMBIA NORTHWEST PHARMACEUTICALS, 2014* 28
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by Auckland UniServices Limited, 2014* 29
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by AB Science, 2014* 30
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2014* 31
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for Addiction and Mental Health, 2014* 32
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 33
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2014* 34
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Luke's-Roosevelt Hospital Center, 2014* 35
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Barcelona, 2014* 36
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 37
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014* 38
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2014* 39
Dysthymia Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014* 40

List of Figures
Dysthymia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Dysthymia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Dysthymia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Dysthymia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Dysthymia Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Dysthymia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Dysthymia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Dysthymia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Dysthymia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Dysthymia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Dysthymia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Dysthymia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Dysthymia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Dysthymia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Dysthymia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Dysthymia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Dysthymia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Dysthymia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Dysthymia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Dysthymia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 65

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.